Christopher Wright
Direktor/Vorstandsmitglied bei ALKERMES PLC
Vermögen: 228 782 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Richard Pops | M | 62 | 33 Jahre | |
| Blair Jackson | M | 51 | 25 Jahre | |
| Shane Cooke | M | 61 | 13 Jahre | |
| David Gaffin | M | 52 | 8 Jahre | |
| Richard Gaynor | M | 74 | 5 Jahre | |
| Emily Alva | F | 49 | 3 Jahre | |
| C. Nichols | M | - | 5 Jahre | |
| Cato Laurencin | M | 65 | 3 Jahre | |
| Andy Wilson | M | 65 | 5 Jahre | |
| Declan O’Connor | M | - | 13 Jahre | |
| Dave Daglio | M | - | 4 Jahre | |
| Brian McKeon | M | 61 | 4 Jahre | |
| Nancy Snyderman | M | 72 | 8 Jahre | |
| Stephen Schiavo | M | - | 6 Jahre | |
| Kanchan Relwani | M | - | 7 Jahre | |
| John Huynh | M | - |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 3 Jahre |
| Spencer Fisk | M | - |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Heather Faulds | F | - | 4 Jahre | |
| Thomas Harvey | M | - | 19 Jahre | |
| Katie Joyce | F | - | - | |
| Anne Giovanoni | F | - | - | |
| Sandy Coombs | F | - | 15 Jahre | |
| Rahul Singhvi | M | 59 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 5 Jahre |
| Peter Norman | M | - | 11 Jahre | |
| Craig Hopkinson | M | 56 | 7 Jahre | |
| Tu Yen Ong | M | 49 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Konstantin Konstantinov | M | 66 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 1 Jahre |
| Francois Nader | M | 67 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 3 Jahre |
| Markus Haeberlein | M | - | - | |
| Juan Andres | M | 59 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Niels Borgstein | M | - | 3 Jahre | |
| Christopher McNulty | M | 47 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 1 Jahre |
| Sondra Smyrnios | F | - | 5 Jahre | |
| David Epstein | M | 62 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 2 Jahre |
| B. Parshall | F | 70 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 2 Jahre |
| Noubar Afeyan | M | 60 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Michael Landine | M | 70 | 13 Jahre | |
| Samuel Parisi | M | 49 | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wendy Dixon | M | 68 | 11 Jahre | |
| Nancy Wysenski | F | 66 | 10 Jahre | |
| David Anstice | M | 75 | 14 Jahre | |
| Iain Brown | M | 55 | 21 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Irland | 31 | 73,81% |
| Vereinigte Staaten | 11 | 26,19% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Christopher Wright
- Persönliches Netzwerk
